Uno S, Motegi Y, Minehata K, Aoki Y, et al. Lenalidomide treatment of Japanese patients with myelodysplastic syndromes with 5q deletion: a post-marketing surveillance study. Int J Hematol 2023;118:432-442.
PMID: 37493867